Responses to Backward Walking Training Post-Stroke
Launched by VA OFFICE OF RESEARCH AND DEVELOPMENT · Jun 9, 2021
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a special training program that involves walking backward to help improve balance and walking ability in veterans who have had a stroke. Researchers want to find out how many sessions of this backward walking training are most effective—either 18 or 27 sessions. They will also look at brain activity using a type of scan called magnetic resonance imaging (MRI) to see how the brain responds to the training and which veterans benefit the most from it.
To participate in this study, veterans must be between 65 and 87 years old, have had a stroke more than two months but less than four months ago, and have some difficulty walking or balancing. They should be able to walk at least 10 feet with minimal assistance. Participants will receive the backward walking training and undergo MRI scans before and after the training to help researchers understand how well the program works. It's important to know that certain health conditions, like severe heart problems or other neurological issues, may prevent someone from joining the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Berg Balance Scale \< 45
- • Self-selected 10 meter gait speed \< 0.8 m/s
- • Diagnosis of unilateral stroke
- • \> 2 months \< 4 months post-stroke
- • Able to ambulate at least 10 feet with maximum 1 person assist
- • Medically stable
- Exclusion Criteria:
- • Presence of neurological condition other than stroke
- • Serious cardiac conditions (hospitalization for myocardial infarction or heart surgery within 3 months, history of congestive heart failure, documented serious and unstable cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, angina or dyspnea at rest or during activities of daily living)
- • Anyone meeting New York Heart Association criteria for Class 3 or Class 4 heart disease will be excluded
- • Severe arthritis or orthopedic problems that limit passive ranges of motion of lower extremity (knee flexion contracture of -10 degrees, knee flexion ROM \< 90 degrees, hip flexion contracture \> 25 degrees, and ankle plantar flexion contracture \> 15 degrees)
- • Severe hypertension with systolic greater than 200 mmHg and diastolic greater than 110 mmHg at rest
- • Pain upon ambulation
- • Receiving physical therapy services for mobility and/or gait
- • Living in a skilled nursing facility
- • Any MRI contraindication, including but not limited to the presence of metal, MR sensitive implanted medical devices, or claustrophobia
About Va Office Of Research And Development
The VA Office of Research and Development (ORD) is dedicated to advancing the health and well-being of veterans through innovative research initiatives. As a pivotal sponsor of clinical trials, ORD focuses on a broad spectrum of health-related topics, including mental health, rehabilitation, and chronic disease management, ensuring that findings are directly applicable to the unique needs of the veteran population. With a commitment to scientific excellence and collaboration, ORD promotes rigorous study designs and ethical standards, facilitating the translation of research discoveries into improved clinical practices and policies that enhance veteran care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Gainesville, Florida, United States
Jacksonville, Florida, United States
Gainesville, Florida, United States
Patients applied
Trial Officials
Dorian Kay Rose, PhD MS BS
Principal Investigator
North Florida/South Georgia Veterans Health System, Gainesville, FL
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials